Revolution Medicines (RVMD) Interest Coverage Ratio (2019 - 2026)

Name: Revolution Medicines (RVMD) Interest Coverage Ratio (2019 - 2026) | Business Quant
Creator: Business Quant

Revolution Medicines' quarterly Interest Coverage Ratio came in at 36.5 in Q1 2026, up 23.27% quarter-over-quarter from 47.57 in Q4 2025.

Revolution Medicines has reported Interest Coverage Ratio for 6 years, with the latest figure at 36.5 in Q1 2026.

For the quarter ending Q1 2026, Interest Coverage Ratio changed N/A year-over-year to 36.5; the trailing twelve-month figure through Mar 2026 stood at 38.89 (changed N/A YoY), and the FY2025 full-year result was 6420.89, changed N/A from the prior year.
Interest Coverage Ratio for Q1 2026 stood at 36.5, up from 47.57 in the prior quarter.
The five-year high for Interest Coverage Ratio was 27.59 in Q3 2025, with the low at 50.15 in Q1 2024.
Average Interest Coverage Ratio over 3 years is 40.45, with a median of 42.04 recorded in 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Quantum Biopharma	1,216,509.61 Bn	1,216,509.61 Bn	-	-129.79
2	Alterity Therapeutics	764,224.41 Bn	764,224.38 Bn	-	-
3	Legend Biotech	2,716.00 Bn	2,715.71 Bn	242.10 Mn	3.58
4	Nanobiotix	2,248.83 Bn	2,248.77 Bn	-	-
5	Akari Therapeutics	1,951.18 Bn	1,951.17 Bn	-	-258.33
6	Vertex Pharmaceuticals	113.69 Bn	106.44 Bn	2.59 Bn	-
7	Evaxion A	64.16 Bn	64.14 Bn	-	11.50
8	Regeneron Pharmaceuticals	63.94 Bn	55.18 Bn	3.31 Bn	49.84
9	Alnylam Pharmaceuticals	40.13 Bn	37.12 Bn	959.66 Mn	3.88
10	Revolution Medicines	31.20 Bn	31.20 Bn	-	-36.50

Download Data 🔒